COVID-19疫情造成全球大流行與高死亡率，2021年5月台灣爆發社區感染疫情，全國疫情提升為3級警戒，各醫療院所嚴加戒備提出因應策略應戰。血液透析病人因有慢性共病及免疫力低下，加上每周三次透析治療，與醫護人員近距離接觸，處於群聚的醫療環境，為感染COVID-19的高危險性族群。為落實各項防疫措施除門戶管制、TOCC、測量體溫，安排疑似或有接觸史之病人進行篩檢外，更依病人篩檢結果安排紅、黃、綠艙別透析，禁止病人轉換艙別，鼓勵疫苗接種，建立透析line官方，發送單位即時訊息。於5月至今，單位內無確診案例，醫護及工作人員100%完成2劑疫苗施打，90.2%透析病人完成2劑疫苗施打。為使血液透析病人出入安心，依疫情變化時時檢視、調整因應措施，以維護整體之安全，期望提供此防疫經驗，能引領透析團隊共同迎戰新冠病毒。

COVID-19 pandemic infection spread worldwide and lead high mortality rate, causing a local transmission outbreak in Taiwan in May 2021. The Central Epidemic Command Center (CECC) therefore raised COVID-19 alert level to Level 3, and the medical institutions were strictly guarded and proposed countermeasures. Hemodialysis patients were at high risk of COVID-19 infection because of the features of multiple comorbidities, compromised immune system, 3.5 to 4-hour restriction in an indoor environment thrice a week, frequent and close contact with medical staff .To respond to the COVID-19 pandemic, we applied entry access control with body temperature checked, TOCC (Travel/Occupation/Contact/Cluster) history for visitors, and fever screening and health evaluation for individuals who had contact with a COVID-19 patient. In addition, we advocated isolation and triage measures for patients from a different source and results of screening, COVID-19 vaccination injection if no contraindications, and LINE official account for dialysis patients to provide information. From May 2021, there was no COVID-19 confirmed infected case in our hemodialysis unit. Besides, all medical staff was vaccinated 2 doses for COVID-19, and up to 90.2% of our dialysis patients also received 2 doses of the COVID-19 vaccine. For the safety of Dialysis patients, We needed to review and adjust prevention programs according to epidemic conditions accordingly. We hope our experience with COVID-19 epidemic prevention can lead the dialysis team to cope with COVID-19 and future epidemics.